Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon- coated polytetrafluoroethylene vascular grafts James Laredo, MD, PhD, Lian Xue, MD, PhD, Vicki A. Husak, BS, Joan Ellinger, BS, Gundeep Singh, MD, Paul O. Zamora, PhD, Howard P. Greisler, MD Journal of Vascular Surgery Volume 39, Issue 5, Pages 1059-1065 (May 2004) DOI: 10.1016/j.jvs.2003.12.025
Fig 1 Histologic parameters measured in silyl-heparin and control grafts for both chronic 7-day and 30-day groups are summarized. A, Graft thrombus length. B, Graft average thrombus height. C, Graft thrombus area. D, Maximal height of graft thrombus (n = 5, mean ± SD, P = .0451 by Wilcoxon rank sum test). Journal of Vascular Surgery 2004 39, 1059-1065DOI: (10.1016/j.jvs.2003.12.025)
Fig 2 The percentage of silyl-heparin and control graft length free of thrombus is shown for both 7-day and 30-day groups of dogs (n = 5, mean ± SD, P = .0451 by Wilcoxon rank sum test). Journal of Vascular Surgery 2004 39, 1059-1065DOI: (10.1016/j.jvs.2003.12.025)